Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2633]

ENA 2020: Inhibitor of KRAS gene mutation shows promise in lung, bowel and other solid tumours

ENA 2020: Inhibitor of KRAS gene mutation shows promise in lung, bowel and other solid tumours

ENA 2020: Next generation BRAF inhibitor cancer drug shows promise in early patient trial

ENA 2020: Next generation BRAF inhibitor cancer drug shows promise in early patient trial

ASTRO: Proton therapy for lung cancer may help reduce risk of heart diseases

ASTRO: Proton therapy for lung cancer may help reduce risk of heart diseases

ENA 20: Vaccine designed to treat and prevent lung, bowel and pancreatic cancer shows promise in the lab

ENA 20: Vaccine designed to treat and prevent lung, bowel and pancreatic cancer shows promise in the lab

75 per cent drop in UK urgent lung cancer referrals during lockdown say experts

75 per cent drop in UK urgent lung cancer referrals during lockdown say experts

Oncotarget: Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance

Oncotarget: Exosomal lncRNA PCAT-1 promotes Kras-associated chemoresistance

A call for more comprehensive smoking cessation programs for cancer patients who smoke

A call for more comprehensive smoking cessation programs for cancer patients who smoke

Oncotarget: Efavirenz induces DNA damage response pathway in lung cancer

Oncotarget: Efavirenz induces DNA damage response pathway in lung cancer

Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks

FDA Approves Nivolumab and Ipilimumab for Unresectable Malignant Pleural Mesothelioma

FDA Approves Nivolumab and Ipilimumab for Unresectable Malignant Pleural Mesothelioma

More from ecancer